Friday, August 22, 2025

US Cannabis: How Will New York Play Out? – The Daily Dive Featuring Bruce Linton

Joining back on the Daily Dive is Bruce Linton, founder and former CEO of Canopy Growth Corporation (TSX: WEED). He gives us an update fresh from stepping down from Gage Growth (CSE: GAGE), the details behind the termination of merger between Red Light Holland (CSE: TRIP) and Creso Pharma (ASX: CPH), and a potential tech project he’s working on. Further, he also shares his view on the outlook of the cannabis industry and its legalization, specifically in New York.

Creso Pharma is an ASX-listed issuer with operations focused on the use of cannabis and hemp across Canada, Europe, Latin America and Australia. In Canada, the company operates its licensed producer, Mernova Medicinal, in Nova Scotia, which focuses on high quality cannabis production. It’s European operations meanwhile are based in Switzerland, where it focuses on its Animal Health, Nutraceutical, and Cosmetics divisions.


FULL DISCLOSURE: Creso Pharma is a client of Canacom Group, the parent company of The Deep Dive. The author has been compensated to cover Creso Pharma on The Deep Dive, with The Deep Dive having full editorial control. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security.

Video Articles

A Medical Breakthrough the Market Overlooked | David Elsley – Cardiol Therapeutics

Why Grade Beats Size in Silver Mining | Frank Basa – Nord Precious Metals

Are Investors Missing the Start of the Next Commodity Supercycle? | Morgan Lekstrom – NexMetals

Recommended

Emerita Resources Expands El Cura Drill Program By 10,000 Metres As Deposit Remains Open For Expansion

ESGold Signs MOU For Tailings Project In Colombia With Grades Up To 42 g/t Gold, 280 g/t Silver

Related News

Why Grade Beats Size in Silver Mining | Frank Basa – Nord Precious Metals

In this interview, Frank Basa, Chairman and CEO of Nord Precious Metals (TSXV: NTH), walks...
Monday, August 18, 2025, 02:14:00 PM

Lobo Tiggre: Evaluating Resource Companies – The Daily Dive

Today on the Daily Dive, we see our host Cassandra Leah sit down with Lobo...

Thursday, February 4, 2021, 01:30:00 PM

A Heart Disease Cure For Pericarditis? Phase 3 Trial Advances | David Elsley – Cardiol Therapeutics

Discover the major breakthrough at Cardiol Therapeutics (NASDAQ: CRDL) (TSX: CRDL) as CEO David Elsley...
Saturday, April 26, 2025, 11:38:00 AM

Trading: It’s Easier To Eliminate The Losers Than Pick The Winners – The Daily Dive feat David Barse

For our Sunday edition of the Daily Dive, our host Cassandra Leah sits down with...

Sunday, March 28, 2021, 01:30:00 PM

First Helium: A Self-Funded Helium Exploration Play – The Daily Dive

Closing out the week on The Daily Dive is that of Ed Bereznicki, CEO of...

Friday, April 8, 2022, 01:30:00 PM